2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
3
INDUSTRY
3
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
42
Esophageal Neoplasms
24
Stomach Neoplasms
21
Rectal Neoplasms
15
Carcinoma, Non-Small-Cell Lung
14
Colorectal Neoplasms
12
Neoplasms
10
Brain Neoplasms
10
Triple Negative Breast Neoplasms
9
Lung Neoplasms
9
Small Cell Lung Carcinoma
8
Squamous Cell Carcinoma of Head and Neck
7
Neoplasm Metastasis
6
Esophageal Squamous Cell Carcinoma
6
Lymphoma, Large B-Cell, Diffuse
5
Carcinoma, Hepatocellular
5
Recurrence
4
Radiation Injuries
4
Nasopharyngeal Carcinoma
4
Melanoma
4
Lymphoma, Extranodal NK-T-Cell
4
Head and Neck Neoplasms
4
Uterine Cervical Neoplasms
3
Meningeal Carcinomatosis
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Hormone Receptor Positive Advanced Breast Cancer
3
HER2-positive Breast Cancer
3
Colonic Neoplasms
3
Vomiting
2
Interventions
1-dodecylpyridoxal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Platinum-resistant Recurrent Ovarian Cancer
×
Clear all
NCT04348032
2022-03-31
APPROVE
ChineseAMS
Phase 2
Unknown
152 enrolled